Ignite Creation Date:
2024-07-17 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481735
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-22
Brief Title:
TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in rr B-ALL
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Organization Data
Organization:
Chinese PLA General Hospital
Class:
OTHER
Study ID:
CHN-PLAGH-BT-087
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese PLA General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Han weidong
Responsible Party Title:
Director of Biotherapeutic Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese PLA General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peking University | OTHER |
| EdiGene Inc | INDUSTRY |